US Patent Issued to ITabMed (HK) on March 17 for "Multispecific antigen binding proteins capable of binding CD19 and CD3, and use thereof" (Chinese Inventors)

ALEXANDRIA, Va., March 17 -- United States Patent no. 12,577,305, issued on March 17, was assigned to ITabMed (HK) Ltd. (Hong Kong).

"Multispecific antigen binding proteins capable of binding CD19 and CD3, and use thereof" was invented by Zhihua Huang (Shanghai), Wuzhong Shen (Shanghai), Yiqun Rao (Shanghai), Yumin Cui (Shanghai) and Xiaoqiang Yan (Shanghai).

According to the abstract* released by the U.S. Patent & Trademark Office: "Provided are multispecific antigen binding proteins (MSAPs) that specifically bind to CD3 and CD19. Further provided are uses of the MSAPs for the preparation of pharmaceutical compositions, methods of treating cancer, and kits comprising the MSAPs."

The patent was filed on Dec. 23, 2019, under Application N...